Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.655 USD | +0.33% | -4.15% | -24.16% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.16% | 1.04B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.47% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
+27.16% | 12.05B | |
-3.63% | 11.7B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : GlaxoSmithKline's COVID-19 Drug Candidate Under Review in Europe